SofWave Medical Ltd.
SOFWF
$7.15
$0.9715.70%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.92% | 18.56% | 16.07% | 23.65% | 31.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.92% | 18.56% | 16.07% | 23.65% | 31.25% |
| Cost of Revenue | 11.72% | 11.09% | 8.30% | 18.45% | 26.75% |
| Gross Profit | 21.39% | 21.16% | 18.86% | 25.50% | 32.87% |
| SG&A Expenses | 19.73% | 12.06% | 2.12% | -2.16% | -0.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.44% | 8.45% | 0.88% | -1.31% | 1.80% |
| Operating Income | 31.27% | 55.19% | 66.73% | 76.24% | 69.04% |
| Income Before Tax | 20.51% | 50.91% | 64.76% | 74.30% | 69.76% |
| Income Tax Expenses | 769.57% | 2,962.50% | -9.59% | -11.30% | -85.67% |
| Earnings from Continuing Operations | 13.81% | 45.08% | 63.36% | 73.10% | 70.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.81% | 45.08% | 63.36% | 73.10% | 70.04% |
| EBIT | 31.27% | 55.19% | 66.73% | 76.24% | 69.04% |
| EBITDA | 42.84% | 66.63% | 77.59% | 83.90% | 74.94% |
| EPS Basic | 14.73% | 45.34% | 63.47% | 73.12% | 70.03% |
| Normalized Basic EPS | 21.34% | 51.12% | 64.90% | 74.35% | 69.78% |
| EPS Diluted | 13.91% | 44.80% | 63.09% | 73.12% | 70.03% |
| Normalized Diluted EPS | 21.34% | 51.12% | 64.90% | 74.35% | 69.78% |
| Average Basic Shares Outstanding | 1.09% | 0.53% | 0.28% | 0.15% | 0.04% |
| Average Diluted Shares Outstanding | 1.09% | 0.53% | 0.28% | 0.15% | 0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |